Johnson & Johnson

Johnson & Johnson is a leading American multinational corporation specializing in pharmaceuticals, biotechnology, and medical devices. Established in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson, the company has grown into one of the world's most influential healthcare organizations.

In 2023, Johnson & Johnson restructured its operations by spinning off its consumer healthcare division into a new publicly traded company named Kenvue. This strategic move allowed Johnson & Johnson to concentrate exclusively on its core areas: Innovative Medicine and MedTech.

Innovative Medicine

Johnson & Johnson's Innovative Medicine segment focuses on developing and producing pharmaceutical prescription drugs. The company invests heavily in research and development, with a reported $15 billion allocated in 2023, making it one of the largest investors in life sciences R&D.

Therapeutic areas include immunology, oncology, neuroscience, infectious diseases, and vaccines. Notable products include treatments for rheumatoid arthritis, cancer therapies, and vaccines for diseases like COVID-19.

MedTech

The MedTech division encompasses a wide range of medical devices and diagnostic equipment including:

• Cardiovascular care
• Orthopedics
• Neurovascular care
• General surgery
• Vision care

The acquisition of companies like Abiomed and Shockwave Medical has bolstered its capabilities in heart devices and interventional solutions.

Global Presence

With a workforce of approximately 138,000 employees worldwide, Johnson & Johnson operates in over 60 countries. Its global footprint includes manufacturing facilities, research and development centers, and sales offices.

Its significant locations in the United States include its headquarters in New Brunswick, New Jersey, as well as facilities in:

• Charleston, WV, USA
• Boise, ID, USA
• Rockford, IL, USA

Recent Developments

In 2025, Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, a move aimed at expanding its portfolio in the neuroscience sector.

This acquisition aligns with the company's strategy to enhance its position in high-growth, high-innovation markets.

Commitment to Innovation

Johnson & Johnson remains dedicated to advancing healthcare through continuous innovation. The company is actively involved in developing treatments for complex diseases, striving to improve patient outcomes and quality of life.

Its commitment to research and development underscores its role as a leader in the healthcare industry.

In summary, Johnson & Johnson's focus on pharmaceuticals and medical devices, coupled with its global operations and dedication to innovation, positions it as a pivotal entity in the healthcare sector.